The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumTranscripts - Operator Good morning, everyone, and thank you for joining the Zevra Therapeutics Corporate Update Call to announce the acquisition of Acer Therapeutics. [Operator Instructions] Today’s … Continue Reading
Read nowInsights - GLP-1, initially touted as a therapy for diabetes, have proven successful for weight loss, CV event reduction, and with beneficial effects in HFpEF. Weight is … Continue Reading
Read nowInsights - This morning the Biden administration unveiled the first 10 drugs that are going to be subject to price “negotiations” between manufacturers and Medicare, according to the Inflation … Continue Reading
Read nowEducation - Cancer companies usually accompany data readouts, conference posters or presentations with various types of graphs and plots to represent the outcomes. This note will go … Continue Reading
Read nowTranscripts - Operator Good day, and thank you for standing by. Welcome to today’s discussion with BridgeBio, which will cover the company’s accurate CM Phase III results … Continue Reading
Read nowDigital Conferences - Replay </div><script></script> Transcript of Call: Participants Mike Kelly, NervGen CEO Dan Mikol, NervGen CMO Rich Macary, KOL Deniel Mero, PropThink Editor PropThink Good morning everyone, … Continue Reading
Read nowInsights - Medtronic announced better than expected Q1 fiscal year 2024 results yesterday. The diabetes segment of the business generated quarterly sales of $578M, more than 6% … Continue Reading
Read now
